Viewing Study NCT00254904

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:15 PM
Ignite Modification Date: 2026-02-25 @ 6:53 PM
Study NCT ID: NCT00254904
Status: TERMINATED
Last Update Posted: 2015-03-30
First Post: 2005-11-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced carcinoma, non-small cell lung, Phase III, Gemcitabine, Gemzar, Cisplatin, … View